Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery - Wikidata - awgldk - TriplyDB

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

http://www.wikidata.org/entity/Q35198350

about

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives Driving DNA transposition by lentiviral protein transduction DNA transposon-based gene vehicles - scenes from an evolutionary drive Gammaretroviral vectors: biology, technology and application Effective gene trapping mediated by Sleeping Beauty transposon.An efficient low cost method for gene transfer to T lymphocytes Influence of untranslated regions on retroviral mRNA transfer and expression Genomic analysis of Sleeping Beauty transposon integration in human somatic cells.Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors The Sleeping Beauty transposon system for clinical applications.Recent developments in transposon-mediated gene therapy.Technological overview of iPS induction from human adult somatic cells.Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery.Viral and Synthetic RNA Vector Technologies and Applications.Sleeping Beauty transposition: from biology to applications.Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side.Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.Stem cell models of polyglutamine diseases and their use in cell-based therapies.Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors.Vector modifications to eliminate transposase expression following piggyBac-mediated transgenesis Feeder-free reprogramming of human fibroblasts with messenger RNA.Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase.Gateway-compatible transposon vector to genetically modify human embryonic kidney and adipose-derived stromal cells.An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout

P2860

Q26861563-2F1BCDBF-BB21-42AF-9EB1-6A406BBF3217 Q28074002-A2D207CB-4674-49AE-A4F1-FB7ECA49143A Q28655839-7922E40A-F7E1-408A-A7C4-533D8D78CDAA Q28660891-38DAC977-A574-4C4C-9585-856E280A72D1 Q34223822-2D6AEAEC-EA53-41E2-9697-4DD3C3F225E7 Q34406272-6912A964-BCD7-4FF3-8612-653341C50E67 Q34653719-94C50E37-D6A0-436F-B429-E50258B2EAA3 Q34668961-CAE1D4BE-E523-47F2-BE98-A7ADB59D9BAC Q35413268-0B29657A-847D-4E98-BC54-FE901E1843A1 Q35618845-D749E7C8-B9F2-4377-B2DB-473685CCC0DB Q36675313-B93A9E0E-A8BA-48C0-9513-D625FC30B12B Q37215836-B69B7487-72FF-43B6-90F9-65D35A95E901 Q37606888-ADD16E00-D1FB-4321-80F5-190703613BE3 Q37969195-4FE99915-B7ED-4E6D-B15C-DD8537DA4116 Q38017202-0EF37C07-B936-48C2-8969-9730443BAF68 Q38074176-41AF6A9F-8299-4CDC-92FF-92230B737F8A Q38709200-06909F68-AB92-44FF-AC19-C5EAD479849D Q38885624-ED28FAAC-5EB8-4ECF-B7A3-D230D257BA9F Q38970768-AF0EEB50-9466-4DE3-9446-722389E28A43 Q39145734-FBDCC0B6-85FC-434B-8CEF-B01987C3E22B Q39237421-D874DE29-9EF4-41E4-ABB1-85E305630F03 Q40402774-32F634DB-ADA0-4E57-9A8F-A462EA43C2B5 Q41472176-FAD4C1CC-BDFD-46D3-9853-236996971A59 Q42158445-7E2FF05B-1145-4722-B915-E8E30F0069DE Q42177240-1BC8A453-5336-4E08-A763-3E8A123EECB8 Q42238143-AB265B2C-4C6E-4FAC-8924-1F5B7982347B Q42356031-C1CC2B75-E3FE-4BA4-B353-87D21AF70FD2 Q45877025-7D6AFFF0-9A4C-48E0-8A34-3BF4559FC2B8 Q47549356-42468D12-11AF-44C4-86E5-4FA487EE21BB Q57493531-358C18D4-FF2E-4585-A3C6-94079771FE6D

P2860

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

http://www.wikidata.org/entity/Q35198350

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

@ast

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

@en

type

label

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

@ast

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

@en

prefLabel

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

@ast

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

@en

P1433

Q35198350-41471C93-7841-41A1-99BE-2C6F0AC65D68

P1476

Q35198350-78068B99-09A1-479F-984C-54E049488280

P2093

Q35198350-04288371-8118-4BC8-B1B3-0C5D4AB87C95

Q35198350-063533BA-9E4B-4F9B-9ACA-9ED3DA505B2D

Q35198350-0C64DCC2-10F5-4A68-8E1F-B3C80FE62145

Q35198350-0F6E2D51-20DC-4E25-94A6-F3712FBEB4D9

Q35198350-2B8754E0-DE20-459C-B9DA-54C53B761619

Q35198350-2D0794C7-5EC6-4C0C-82BB-499E43C7131C

Q35198350-5F5310F5-4880-4BF6-9C84-1AA7D4DCF55F

Q35198350-725EBA76-9D3F-4201-9C4B-1D9DF85971A0

Q35198350-A3CE96F8-EC02-478E-B22D-EE1520BD1FB9

Q35198350-AA9B9987-70EF-4CE6-8D5D-B9686EF9AC0C

P2860

Q35198350-01DD8E22-BA00-4A16-BE91-E44348CC37F6

Q35198350-0288691D-DFB0-4F15-8113-D2A078660099

Q35198350-0560E07E-DCC3-4667-83DF-5F53AB6CB65C

Q35198350-061757F2-814A-42C6-8D55-81C4892A2B58

Q35198350-179F13F5-E4B6-4A33-9958-EFFB1DDBD820

Q35198350-1A138559-6660-4736-A38D-D4C271045E28

Q35198350-2385D601-F20F-451C-8383-65FB6767ECBE

Q35198350-25D11D2E-0DA2-44E4-BD17-8238249FF47F

Q35198350-27A356DB-29C8-4E0C-84E0-7B19A743D8E4

Q35198350-2F495692-C2FB-473B-9B08-7A1A9F6D9CF4

P304

Q35198350-5E6F8884-6DB9-4D95-8478-E87283F96C6E

P31

Q35198350-362EC069-E9BF-48EC-B73B-DF3A0834F069

P356

Q35198350-E858E8F8-095E-40B3-8B43-BEF566E60D87

P407

Q35198350-3A266746-ED38-4634-8592-D5B1BA153E79

P433

Q35198350-7E64F759-7B49-403F-90B1-4B47CFA9A405

P478

Q35198350-34A5011A-19AB-4B71-A176-9D90C92AEC61

P50

Q35198350-09EC3956-C542-4D24-A6D7-243B51F36C9E

Q35198350-0EDFAE9A-D6B0-49D7-B2FD-61435F0FD31E

Q35198350-1A128874-F205-4877-B523-4DE84B30C721

P577

Q35198350-980E5432-F913-4A76-B5CF-F897536F87C4

P5875

Q35198350-C3BBFC38-1565-4646-B5FB-EF1CA96BF5D4

P698

Q35198350-70461F9D-0C7C-47BC-9CB3-B264F541DEB5

P921

Q35198350-5BB0180A-C49E-4EAB-B8FF-6CFCC5243F79

P932

Q35198350-1D75A7BF-8133-463B-B513-A475B906B580

P356

P1433

Nucleic Acids Research

P1476

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

@en

P2093

Christine S Falk

http://www.w3.org/2001/XMLSchema#string

Christopher Baum

http://www.w3.org/2001/XMLSchema#string

Daniela Zychlinski

http://www.w3.org/2001/XMLSchema#string

Gudrun Göhring

http://www.w3.org/2001/XMLSchema#string

Johannes Kuehle

http://www.w3.org/2001/XMLSchema#string

Kathrin Lange

http://www.w3.org/2001/XMLSchema#string

Martijn H Brugman

http://www.w3.org/2001/XMLSchema#string

Melanie Galla

http://www.w3.org/2001/XMLSchema#string

Niels Heinz

http://www.w3.org/2001/XMLSchema#string

Tobias Maetzig

http://www.w3.org/2001/XMLSchema#string

P2860

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

A transposon and transposase system for human application

Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates

A third-generation lentivirus vector with a conditional packaging system

Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells

Visualizing spatiotemporal dynamics of multicellular cell-cycle progression

High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells.

Sleeping beauty transposition from nonintegrating lentivirus.

Hybrid lentivirus-transposon vectors with a random integration profile in human cells.

Diverse functions of JNK signaling and c-Jun in stress response and apoptosis.

P304

7147-7160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKR384

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Zychlinski

P577

2011-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51162757

http://www.w3.org/2001/XMLSchema#string

P698

21609958

http://www.w3.org/2001/XMLSchema#string

P921

P932

3167617

http://www.w3.org/2001/XMLSchema#string